chr7-122302075-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001024613.4(FEZF1):c.1350G>A(p.Pro450=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00083 in 1,607,676 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0043 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 4 hom. )
Consequence
FEZF1
NM_001024613.4 synonymous
NM_001024613.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.20
Genes affected
FEZF1 (HGNC:22788): (FEZ family zinc finger 1) This gene encodes a transcriptional repressor that belongs to the zinc finger double domain protein family. The encoded protein is thought to play a role in the embryonic migration of gonadotropin-releasing hormone neurons into the brain. Mutations in this gene are associated with hypogonadotropic hypogonadism-22 with anosmia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 7-122302075-C-T is Benign according to our data. Variant chr7-122302075-C-T is described in ClinVar as [Benign]. Clinvar id is 713972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.2 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FEZF1 | NM_001024613.4 | c.1350G>A | p.Pro450= | synonymous_variant | 4/4 | ENST00000442488.7 | NP_001019784.2 | |
FEZF1 | NM_001160264.2 | c.1200G>A | p.Pro400= | synonymous_variant | 5/5 | NP_001153736.1 | ||
FEZF1 | XM_005250337.4 | c.1350G>A | p.Pro450= | synonymous_variant | 5/5 | XP_005250394.1 | ||
FEZF1 | XM_011516202.3 | c.1200G>A | p.Pro400= | synonymous_variant | 6/6 | XP_011514504.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEZF1 | ENST00000442488.7 | c.1350G>A | p.Pro450= | synonymous_variant | 4/4 | 1 | NM_001024613.4 | ENSP00000411145 | P2 | |
FEZF1 | ENST00000427185.2 | c.1200G>A | p.Pro400= | synonymous_variant | 5/5 | 1 | ENSP00000392727 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00427 AC: 650AN: 152182Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
650
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00106 AC: 252AN: 237800Hom.: 4 AF XY: 0.000811 AC XY: 106AN XY: 130692
GnomAD3 exomes
AF:
AC:
252
AN:
237800
Hom.:
AF XY:
AC XY:
106
AN XY:
130692
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000469 AC: 683AN: 1455376Hom.: 4 Cov.: 31 AF XY: 0.000434 AC XY: 314AN XY: 723998
GnomAD4 exome
AF:
AC:
683
AN:
1455376
Hom.:
Cov.:
31
AF XY:
AC XY:
314
AN XY:
723998
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00427 AC: 651AN: 152300Hom.: 4 Cov.: 32 AF XY: 0.00391 AC XY: 291AN XY: 74470
GnomAD4 genome
AF:
AC:
651
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
291
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 12, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 17, 2020 | - - |
FEZF1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at